ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc (RCKT)

8.76
0.26
(3.06%)
Closed March 16 3:00PM
8.76
0.00
(0.00%)
After Hours: 6:53PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
8.76
Bid
8.50
Ask
8.99
Volume
1,069,813
8.50 Day's Range 8.81
8.06 52 Week Range 28.73
Market Cap
Previous Close
8.50
Open
8.63
Last Trade Time
Financial Volume
US$ 9,254,890
VWAP
8.6509
Average Volume (3m)
1,504,725
Shares Outstanding
106,629,701
Dividend Yield
-
PE Ratio
-0.03
Earnings Per Share (EPS)
-2.3
Revenue
-
Net Profit
-245.6M

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesio... Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Rocket Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RCKT. The last closing price for Rocket Pharmaceuticals was US$8.50. Over the last year, Rocket Pharmaceuticals shares have traded in a share price range of US$ 8.06 to US$ 28.73.

Rocket Pharmaceuticals currently has 106,629,701 shares outstanding. The market capitalization of Rocket Pharmaceuticals is US$906.35 million. Rocket Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.03.

Rocket Pharmaceuticals (RCKT) Options Flow Summary

Overall Flow

Bearish

Net Premium

-36k

Calls / Puts

50.00%

Buys / Sells

50.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

RCKT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.225-2.50417362278.9859.118.0615495528.57710776CS
4-1.5068-14.676432773610.266811.118.0613621279.30795136CS
12-2.445-21.820615796511.20513.358.06150472510.50904895CS
26-11.24-56.22022.018.06125836413.01222632CS
52-19.19-68.658318425827.9528.738.0699431216.56171554CS
156-6.91-44.097000638215.6732.5257.56591540318.24601617CS
260-2.24-20.36363636361167.487.56572692722.32408725CS

RCKT - Frequently Asked Questions (FAQ)

What is the current Rocket Pharmaceuticals share price?
The current share price of Rocket Pharmaceuticals is US$ 8.76
How many Rocket Pharmaceuticals shares are in issue?
Rocket Pharmaceuticals has 106,629,701 shares in issue
What is the market cap of Rocket Pharmaceuticals?
The market capitalisation of Rocket Pharmaceuticals is USD 906.35M
What is the 1 year trading range for Rocket Pharmaceuticals share price?
Rocket Pharmaceuticals has traded in the range of US$ 8.06 to US$ 28.73 during the past year
What is the PE ratio of Rocket Pharmaceuticals?
The price to earnings ratio of Rocket Pharmaceuticals is -0.03
What is the reporting currency for Rocket Pharmaceuticals?
Rocket Pharmaceuticals reports financial results in USD
What is the latest annual profit for Rocket Pharmaceuticals?
The latest annual profit of Rocket Pharmaceuticals is USD -245.6M
What is the registered address of Rocket Pharmaceuticals?
The registered address for Rocket Pharmaceuticals is 300 DELAWARE AVENUE, SUITE 270, WILMINGTON, DELAWARE, 19801
What is the Rocket Pharmaceuticals website address?
The website address for Rocket Pharmaceuticals is www.rocketpharma.com
Which industry sector does Rocket Pharmaceuticals operate in?
Rocket Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M

RCKT Discussion

View Posts
Monksdream Monksdream 3 weeks ago
RCKT 10Q due MONDAY 2/24
👍️0
Monksdream Monksdream 1 year ago
RCKT new 52 week high
👍️0
make it happen make it happen 2 years ago
How's it up 38% @ $21.00 PPS when diluting $175,000,000 million @ $16.00??
👍️0
trkyhntr trkyhntr 4 years ago
I have been away at hunting camp for a few weeks, and when I got back I was pleasantly surprised. This puppy has doubled! Any thoughts as to how much more upside there is?
👍️0
ClayTrader ClayTrader 4 years ago
* * $RCKT Video Chart 12-09-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Glider549 Glider549 5 years ago
Check out Seeking Alpha, January 27, article.
Lots of insider buying and Fast Track status.
👍️0
RUSTYJ RUSTYJ 6 years ago
How you figure a lot power , Gravity takes it down
👍️0
investor86 investor86 7 years ago
This got a lot of power!!
👍️0
trkyhntr trkyhntr 7 years ago
This is a new board for this stock. Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic that the Company has designed to lower intraocular pressure (IOP) by restoring the eye's natural pressure control mechanism. The Company developed this molecule to selectively stimulate a particular adenosine subreceptor in the eye with the effect of augmenting the intrinsic function of the eye's trabecular meshwork (TM). Its product pipeline includes trabodenoson monotherapy delivered in an eye drop formulation, as well as a fixed-dose combination (FDC), of trabodenoson with latanoprost given once-daily (QD). The Company is evaluating the potential of trabodenoson to slow the loss of vision associated with glaucoma and degenerative retinal diseases.
👍️0